ArticleCureus2025
Adenomatous Hyperplasia of Duodenal Brunner's Glands: An Extremely Uncommon Imitation of Malignant Pathology.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenomatous hyperplasia of duodenal Brunner's glands is a rare benign pathology of the duodenum linked to epigastric pain and dyspepsia. However, in rare cases, it can cause intestinal obstruction. Hence, endoscopic or surgical removal of Brunner's gland hyperplasia (BGH) has been suggested to prevent complications including hemorrhage, severe anemia due to persistent bleeding, intussusception, and obstruction. BGH can be managed with endoscopic polypectomy. It represents a less invasive alternative to surgery and is more cost-effective. The medical treatment mainly involves treating gastric hyperacidity, a known cause of BGH, but the regression of BGH is rare. This case report aims to describe and investigate the clinicopathologic features of this rare pathology. The case emphasizes the importance of endoscopy for the evaluation of the refractory gastroesophageal reflux-like presentation and demonstrates that histopathological evaluation remains critical for a definitive diagnosis of BGH and to rule out malignancy. Conservative approaches may suffice in select patients, avoiding invasive interventions. Follow-up remains essential to monitor for recurrence or complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.